000 | 01937 a2200517 4500 | ||
---|---|---|---|
005 | 20250513211346.0 | ||
264 | 0 | _c20000620 | |
008 | 200006s 0 0 eng d | ||
022 | _a0006-291X | ||
024 | 7 |
_a10.1006/bbrc.2000.2665 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYamakawa, K | |
245 | 0 | 0 |
_aPeroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells. _h[electronic resource] |
260 |
_bBiochemical and biophysical research communications _cMay 2000 |
||
300 |
_a571-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcetophenones _xpharmacology |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aChromans _xpharmacology |
650 | 0 | 4 |
_aEndothelial Growth Factors _xmetabolism |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLymphokines _xmetabolism |
650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
650 | 0 | 4 |
_aPeroxisome Proliferators _xpharmacology |
650 | 0 | 4 | _aPioglitazone |
650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xagonists |
650 | 0 | 4 |
_aTetrazoles _xpharmacology |
650 | 0 | 4 |
_aThiazoles _xpharmacology |
650 | 0 | 4 | _aThiazolidinediones |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTranscription Factors _xagonists |
650 | 0 | 4 | _aTroglitazone |
650 | 0 | 4 | _aVascular Endothelial Growth Factor A |
650 | 0 | 4 | _aVascular Endothelial Growth Factors |
650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
700 | 1 | _aHosoi, M | |
700 | 1 | _aKoyama, H | |
700 | 1 | _aTanaka, S | |
700 | 1 | _aFukumoto, S | |
700 | 1 | _aMorii, H | |
700 | 1 | _aNishizawa, Y | |
773 | 0 |
_tBiochemical and biophysical research communications _gvol. 271 _gno. 3 _gp. 571-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1006/bbrc.2000.2665 _zAvailable from publisher's website |
999 |
_c10766266 _d10766266 |